免疫肿瘤学-话题@MedSci - williamhill asia

#免疫肿瘤学#

5篇内容 | 1553人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2242627, encodeId=b73a224262ea4, content=<a href='/topic/show?id=8dcd12852f1' target=_blank style='color:#2F92EE;'>#NK细胞#</a> <a href='/topic/show?id=bacf291496a' target=_blank style='color:#2F92EE;'>#免疫肿瘤学#</a>, objectTitle=激活NK细胞：靶向NKG2D配体, objectType=article, longId=855443, objectId=434885544397, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/filling-medical-history-XZB9RVX.jpg, objectUrl=/article/show_article.do?id=434885544397, replyNumber=0, likeNumber=46, createdTime=2024-12-15, rootId=0, userName=williamhill asia 管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=434885544397, moduleTitle=激活NK细胞：靶向NKG2D配体, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=434885544397)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2175112, encodeId=d91a21e511221, content=<a href='/topic/show?id=50d6e0215a' target=_blank style='color:#2F92EE;'>#ESMO#</a> <a href='/topic/show?id=33771982175' target=_blank style='color:#2F92EE;'>#三阴性乳腺癌#</a> <a href='/topic/show?id=c3f910342343' target=_blank style='color:#2F92EE;'>#鼻咽癌#</a> <a href='/topic/show?id=bacf291496a' target=_blank style='color:#2F92EE;'>#免疫肿瘤学#</a>, objectTitle=2023 ESMO IO｜早期治疗的免疫肿瘤学探索, objectType=article, longId=805052, objectId=296180505267, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/conference-with-doctors-in-medical-aprons-PT29AAG.jpg, objectUrl=/article/show_article.do?id=296180505267, replyNumber=0, likeNumber=144, createdTime=2023-12-15, rootId=0, userName=williamhill asia 管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=296180505267, moduleTitle=2023 ESMO IO｜早期治疗的免疫肿瘤学探索, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=296180505267)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1735882, encodeId=45cb1e358826b, content=<a href='/topic/show?id=bacf291496a' target=_blank style='color:#2F92EE;'>#免疫肿瘤学#</a>, objectTitle=2019全球十大免疫肿瘤学初创公司榜单出炉, objectType=article, longId=184188, objectId=1d9c18418874, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1d9c18418874, replyNumber=0, likeNumber=92, createdTime=2020-08-17, rootId=0, userName=wgx317, userId=1aba34025754, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1d9c18418874, moduleTitle=2019全球十大免疫肿瘤学初创公司榜单出炉, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=1d9c18418874)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1735881, encodeId=25db1e35881c7, content=<a href='/topic/show?id=bacf291496a' target=_blank style='color:#2F92EE;'>#免疫肿瘤学#</a>, objectTitle=2019ASCO：这些免疫肿瘤学靶标新秀值得关注, objectType=article, longId=167349, objectId=0abf16e34933, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0abf16e34933, replyNumber=0, likeNumber=79, createdTime=2019-09-02, rootId=0, userName=wgx317, userId=1aba34025754, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0abf16e34933, moduleTitle=2019ASCO：这些免疫肿瘤学靶标新秀值得关注, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=0abf16e34933)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1735880, encodeId=34211e35880ae, content=<a href='/topic/show?id=bacf291496a' target=_blank style='color:#2F92EE;'>#免疫肿瘤学#</a>, objectTitle=诺华与Xencor签署26亿美元协议，加强免疫肿瘤学（IO）资产, objectType=article, longId=71962, objectId=31b8e196232, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=31b8e196232, replyNumber=0, likeNumber=94, createdTime=2016-07-13, rootId=0, userName=wgx317, userId=1aba34025754, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=31b8e196232, moduleTitle=诺华与Xencor签署26亿美元协议，加强免疫肿瘤学（IO）资产, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=31b8e196232)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1735879, encodeId=57341e35879ae, content=<a href='/topic/show?id=bacf291496a' target=_blank style='color:#2F92EE;'>#免疫肿瘤学#</a>, objectTitle=WCC 2014 ：免疫肿瘤学：癌症转化医学, objectType=article, longId=44381, objectId=612c443812c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=612c443812c, replyNumber=0, likeNumber=81, createdTime=2015-11-16, rootId=0, userName=wgx317, userId=1aba34025754, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=612c443812c, moduleTitle=WCC 2014 ：免疫肿瘤学：癌症转化医学, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=612c443812c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1735878, encodeId=0a551e358784f, content=<a href='/topic/show?id=bacf291496a' target=_blank style='color:#2F92EE;'>#免疫肿瘤学#</a>, objectTitle=阿斯利康和Advaxis合作开发免疫肿瘤学组合疗法, objectType=article, longId=38199, objectId=460e38199d1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=460e38199d1, replyNumber=0, likeNumber=105, createdTime=2015-01-27, rootId=0, userName=wgx317, userId=1aba34025754, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=460e38199d1, moduleTitle=阿斯利康和Advaxis合作开发免疫肿瘤学组合疗法, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=460e38199d1)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] williamhill asia 话题小助手

免疫肿瘤学

2020-05-29

williamhill asia 管理员 (审核中...)

前往app查看评论内容

#NK细胞# #免疫肿瘤学#

激活NK细胞：靶向NKG2D配体

2024-12-15发表于陕西省

williamhill asia 管理员 (审核中...)

前往app查看评论内容

#ESMO# #三阴性乳腺癌# #鼻咽癌# #免疫肿瘤学#

2023 ESMO IO｜早期治疗的免疫肿瘤学探索

2023-12-15发表于上海

wgx317 (审核中...)

前往app查看评论内容

#免疫肿瘤学#

2019全球十大免疫肿瘤学初创公司榜单出炉

2020-08-17

wgx317 (审核中...)

前往app查看评论内容

#免疫肿瘤学#

2019ASCO：这些免疫肿瘤学靶标新秀值得关注

2019-09-02

wgx317 (审核中...)

前往app查看评论内容

#免疫肿瘤学#

诺华与Xencor签署26亿美元协议，加强免疫肿瘤学（IO）资产

2016-07-13

wgx317 (审核中...)

前往app查看评论内容

#免疫肿瘤学#

WCC 2014 ：免疫肿瘤学：癌症转化医学

2015-11-16

wgx317 (审核中...)

前往app查看评论内容

#免疫肿瘤学#

阿斯利康和Advaxis合作开发免疫肿瘤学组合疗法

2015-01-27

科室
- - 订阅+
  - 更多科室
工具
服务